PATENT CLAIM ANALYSIS

Application Number: 15868458
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "230500"]

Abstract:
The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.

Claim (Index 21):
The method of  claim 19 , wherein the neurodegenerative disease is selected from Alzheimer's disease, ALS, Parkinson's disease, and Huntington's disease.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.23404
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15655583', '14510711', '13546713', '15484445', '13812366']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7305725577483612
- 35 USC 102 Novelty (BERT): 0.5300563259544779
- Combined Prediction Score: 0.7105209345689728
- Mean Citation Score: 293.517768
- Max Citation Score: 320.85504
- Similarity Product: 226.75627857238769

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test